IL-2/B7.1 (CD80) Fusagene Transduction of AML Blasts by a Self-Inactivating Lentiviral Vector Stimulates T Cell Responses in Vitro: a Strategy to Generate Whole Cell Vaccines for AML-Reference-Cited by-同舟云学术

IL-2/B7.1 (CD80) Fusagene Transduction of AML Blasts by a Self-Inactivating Lentiviral Vector Stimulates T Cell Responses in Vitro: a Strategy to Generate Whole Cell Vaccines for AML

Published:2005-01 Issue:1 Volume:11 Page:120-131
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Chan Lucas,Hardwick Nicola,Darling Dave,Galea-Lauri Joanna,Gäken Joop,Devereux Steve,Kemeny Mike,Mufti Ghulam,Farzaneh Farzin

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference49 articles.

1. Acute myeloid leukemia;Giles;Hematology,2002

2. Immunological weapons against acute myeloid leukaemia;Galea-Lauri;Immunology,2002

3. Enhanced immune costimulatory activity of primary acute myeloid leukaemia blasts after retrovirus-mediated gene transfer of B7.1;Hirst;Gene Ther.,1997

4. Expression of costimulatory molecules in human leukemias;Hirano;Leukemia,1996

5. Expression of human leucocyte antigens and co-stimulatory molecules on blasts of patients with acute myeloid leukaemia;Vollmer;Br. J. Haematol.,2003

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD80-Fc fusion protein as a potential cancer immunotherapy strategy;Antibody Therapeutics;2023-11-30

2. Immune microenvironment of cervical cancer and the role of IL-2 in tumor promotion;Cytokine;2023-10

3. A systematic review of interleukin-2-based immunotherapies in clinical trials for cancer and autoimmune diseases;eBioMedicine;2023-04

4. A systematic review of interleukin-2-based immunotherapies in clinical trials for cancer and autoimmune diseases;2022-12-04

5. Current challenges in the manufacture of clinical-grade autologous whole cell vaccines for hematological malignancies;Cytotherapy;2022-10